WEKO3
アイテム
{"_buckets": {"deposit": "38f04861-ec61-4be5-8b7a-54b217420643"}, "_deposit": {"created_by": 3, "id": "6756", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "6756"}, "status": "published"}, "_oai": {"id": "oai:rakuno.repo.nii.ac.jp:00006756", "sets": ["29"]}, "author_link": ["21873", "21874", "21875", "19434", "4715", "20647", "21876", "4914"], "item_2_biblio_info_9": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1", "bibliographicPageEnd": "61", "bibliographicPageStart": "53", "bibliographicVolumeNumber": "83", "bibliographic_titles": [{"bibliographic_title": "Journal of Veterinary Medical Science"}]}]}, "item_2_description_43": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_2_description_6": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We aimed to evaluate the induction, anesthesia, and cardiorespiratory effects of intramuscular (IM) anesthetic protocol with alfaxalone following premedication with low-dose medetomidine, butorphanol, or a combination of both (medetomidine-butorphanol) in dogs. Six healthy beagles were administered 1, 2.5, or 5 mg/kg alfaxalone IM following premedication with low-dose medetomidine (5 μg/kg; MA-IM), butorphanol (0.3 mg/kg; BA-IM), or medetomidinebutorphanol (5 μg/kg and 0.3 mg/kg, respectively; MBA-IM). Each dog received 9 treatments with minimum 7-day washout period between treatments. Dogs were allowed to breath room air during anesthetic induction. We attempted endotracheal intubation after alfaxalone administration. Alfaxalone produced a dose-dependent anesthetic effect in each anesthetic protocol. Intubation was achieved in 4 out of 6 dogs that received MA-IM and BA-IM with 2.5 mg/kg alfaxalone and in all dogs that received MBA-IM with 1, 2.5, and 5 mg/kg alfaxalone. The median durations [minimum-maximum] of accepting intubation were 79 [0-89], 97 [84-120], and 117 [84-217] min, respectively. Hypotension (mean arterial blood pressure \u003c60 mmHg) did not develop, but bradycardia (heart rate \u003c60 beats/min) was observed in all dogs that received the MA-IM and MBA-IM protocols. Severe hypoxemia (percutaneous arterial oxygen saturation \u003c90%) developed in 2 dogs that received MBA-IM with 5 mg/kg alfaxalone. We consider that the MA-IM and BA-IM protocols with ≥2.5 mg/kg alfaxalone and the MBA-IM protocol with 1-2.5 mg/kg alfaxalone could provide clinically useful and effective anesthesia without causing severe cardiorespiratory depression in healthy dogs.", "subitem_description_type": "Abstract"}]}, "item_2_publisher_36": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本獣医学会"}]}, "item_2_relation_11": {"attribute_name": "ISBN", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "0916-7250", "subitem_relation_type_select": "ISBN"}}]}, "item_2_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1292/jvms.20-0330", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_16": {"attribute_name": "権利(URI)", "attribute_value_mlt": [{"subitem_rights": "https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja"}]}, "item_2_version_type_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "KATO, Keiko"}], "nameIdentifiers": [{"nameIdentifier": "21873", "nameIdentifierScheme": "WEKO"}]}, {"creatorAffiliations": [{"affiliationNameIdentifiers": [{"affiliationNameIdentifier": "", "affiliationNameIdentifierScheme": "ISNI", "affiliationNameIdentifierURI": "http://www.isni.org/isni/"}], "affiliationNames": [{"affiliationName": "", "affiliationNameLang": "ja"}]}], "creatorNames": [{"creatorName": "ITAMI, Takaharu", "creatorNameLang": "en"}, {"creatorName": "伊丹, 貴晴", "creatorNameLang": "ja"}], "familyNames": [{"familyName": "ITAMI", "familyNameLang": "en"}, {"familyName": "伊丹", "familyNameLang": "ja"}], "givenNames": [{"givenName": "Takaharu", "givenNameLang": "en"}, {"givenName": "貴晴", "givenNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "20647", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "9465", "nameIdentifierScheme": "教員総覧", "nameIdentifierURI": "https://www.rakuno.ac.jp/archives/teacher/9465.html"}]}, {"creatorNames": [{"creatorName": "NOMOTO, Ken"}], "nameIdentifiers": [{"nameIdentifier": "21874", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "ENDO, Yusuke"}], "nameIdentifiers": [{"nameIdentifier": "21875", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "TAMURA, Jun"}], "nameIdentifiers": [{"nameIdentifier": "21876", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "OYAMA, Norihiko"}], "nameIdentifiers": [{"nameIdentifier": "19434", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "48ea6c6f52052acb", "nameIdentifierScheme": "教員総覧", "nameIdentifierURI": "http://souran.rakuno.ac.jp/profile/ja.48ea6c6f52052acb.html"}]}, {"creatorNames": [{"creatorName": "SANO, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "4914", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "c51ba1efc5c01a2e7a34ca8910f2ede6", "nameIdentifierScheme": "教員総覧", "nameIdentifierURI": "http://souran.rakuno.ac.jp/profile/ja.c51ba1efc5c01a2e7a34ca8910f2ede6.html"}]}, {"creatorAffiliations": [{"affiliationNameIdentifiers": [{"affiliationNameIdentifier": "", "affiliationNameIdentifierScheme": "ISNI", "affiliationNameIdentifierURI": "http://www.isni.org/isni/"}], "affiliationNames": [{"affiliationName": "", "affiliationNameLang": "ja"}]}], "creatorNames": [{"creatorName": "YAMASHITA, Kazuto", "creatorNameLang": "en"}, {"creatorName": "山下, 和人", "creatorNameLang": "ja"}], "familyNames": [{"familyName": "YAMASHITA", "familyNameLang": "en"}, {"familyName": "山下", "familyNameLang": "ja"}], "givenNames": [{"givenName": "Kazuto", "givenNameLang": "en"}, {"givenName": "和人", "givenNameLang": "ja"}], "nameIdentifiers": [{"nameIdentifier": "4715", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "9433", "nameIdentifierScheme": "教員総覧", "nameIdentifierURI": "https://www.rakuno.ac.jp/archives/teacher/9433.html"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-02-21"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "R-2021-27_itami.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "R-2021-27_itami.pdf", "url": "https://rakuno.repo.nii.ac.jp/record/6756/files/R-2021-27_itami.pdf"}, "version_id": "a6b8f36a-383a-4710-83c5-aa22afb768ed"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "alfaxalone", "subitem_subject_scheme": "Other"}, {"subitem_subject": "butorphanol", "subitem_subject_scheme": "Other"}, {"subitem_subject": "dog", "subitem_subject_scheme": "Other"}, {"subitem_subject": "intramuscular anesthesia", "subitem_subject_scheme": "Other"}, {"subitem_subject": "medetomidine", "subitem_subject_scheme": "Other"}, {"subitem_subject": "alfaxalone", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "butorphanol", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "dog", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "intramuscular anesthesia", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "medetomidine", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol"}]}, "item_type_id": "2", "owner": "3", "path": ["29"], "permalink_uri": "http://hdl.handle.net/10659/00006988", "pubdate": {"attribute_name": "公開日", "attribute_value": "2022-02-21"}, "publish_date": "2022-02-21", "publish_status": "0", "recid": "6756", "relation": {}, "relation_version_is_last": true, "title": ["The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol"], "weko_shared_id": -1}
The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol
http://hdl.handle.net/10659/00006988
http://hdl.handle.net/10659/00006988ecd20b65-0992-48d9-8e00-77bd40b051be
名前 / ファイル | ライセンス | アクション |
---|---|---|
R-2021-27_itami.pdf (1.1 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2022-02-21 | |||||
タイトル | ||||||
タイトル | The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | alfaxalone | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | butorphanol | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | dog | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | intramuscular anesthesia | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | medetomidine | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | alfaxalone | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | butorphanol | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | dog | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | intramuscular anesthesia | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | medetomidine | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
KATO, Keiko
× KATO, Keiko× 伊丹, 貴晴× NOMOTO, Ken× ENDO, Yusuke× TAMURA, Jun× OYAMA, Norihiko× SANO, Tadashi× 山下, 和人 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We aimed to evaluate the induction, anesthesia, and cardiorespiratory effects of intramuscular (IM) anesthetic protocol with alfaxalone following premedication with low-dose medetomidine, butorphanol, or a combination of both (medetomidine-butorphanol) in dogs. Six healthy beagles were administered 1, 2.5, or 5 mg/kg alfaxalone IM following premedication with low-dose medetomidine (5 μg/kg; MA-IM), butorphanol (0.3 mg/kg; BA-IM), or medetomidinebutorphanol (5 μg/kg and 0.3 mg/kg, respectively; MBA-IM). Each dog received 9 treatments with minimum 7-day washout period between treatments. Dogs were allowed to breath room air during anesthetic induction. We attempted endotracheal intubation after alfaxalone administration. Alfaxalone produced a dose-dependent anesthetic effect in each anesthetic protocol. Intubation was achieved in 4 out of 6 dogs that received MA-IM and BA-IM with 2.5 mg/kg alfaxalone and in all dogs that received MBA-IM with 1, 2.5, and 5 mg/kg alfaxalone. The median durations [minimum-maximum] of accepting intubation were 79 [0-89], 97 [84-120], and 117 [84-217] min, respectively. Hypotension (mean arterial blood pressure <60 mmHg) did not develop, but bradycardia (heart rate <60 beats/min) was observed in all dogs that received the MA-IM and MBA-IM protocols. Severe hypoxemia (percutaneous arterial oxygen saturation <90%) developed in 2 dogs that received MBA-IM with 5 mg/kg alfaxalone. We consider that the MA-IM and BA-IM protocols with ≥2.5 mg/kg alfaxalone and the MBA-IM protocol with 1-2.5 mg/kg alfaxalone could provide clinically useful and effective anesthesia without causing severe cardiorespiratory depression in healthy dogs. | |||||
書誌情報 |
Journal of Veterinary Medical Science 巻 83, 号 1, p. 53-61, 発行日 2021-01 |
|||||
ISBN | ||||||
識別子タイプ | ISBN | |||||
関連識別子 | 0916-7250 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1292/jvms.20-0330 | |||||
権利(URI) | ||||||
権利情報 | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
出版者 | ||||||
出版者 | 日本獣医学会 | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Article |